Citizens Financial Group Inc. RI Increases Position in IQVIA Holdings Inc. (NYSE:IQV)

Citizens Financial Group Inc. RI increased its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 19.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 2,463 shares of the medical research company’s stock after acquiring an additional 407 shares during the period. Citizens Financial Group Inc. RI’s holdings in IQVIA were worth $584,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Capital Performance Advisors LLP acquired a new position in shares of IQVIA in the third quarter valued at approximately $27,000. Park Place Capital Corp purchased a new position in IQVIA in the 3rd quarter valued at $28,000. Versant Capital Management Inc increased its stake in IQVIA by 733.3% in the 2nd quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock valued at $26,000 after buying an additional 110 shares during the period. Opal Wealth Advisors LLC purchased a new position in IQVIA during the 2nd quarter worth $27,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of IQVIA in the 2nd quarter worth $29,000. 89.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Eric Sherbet sold 1,300 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the sale, the insider now owns 19,536 shares in the company, valued at approximately $4,812,302.88. This trade represents a 6.24 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by company insiders.

IQVIA Stock Performance

IQVIA stock opened at $201.82 on Friday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. IQVIA Holdings Inc. has a fifty-two week low of $187.62 and a fifty-two week high of $261.73. The stock has a fifty day moving average of $222.67 and a two-hundred day moving average of $227.18. The company has a market capitalization of $36.63 billion, a price-to-earnings ratio of 26.49, a PEG ratio of 1.97 and a beta of 1.51.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on IQV shares. Royal Bank of Canada reissued an “outperform” rating and set a $270.00 price target on shares of IQVIA in a report on Friday, November 1st. BTIG Research reduced their price target on IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a report on Friday, November 1st. Barclays dropped their price objective on IQVIA from $260.00 to $255.00 and set an “overweight” rating on the stock in a report on Friday, November 1st. Robert W. Baird reduced their target price on IQVIA from $256.00 to $223.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Finally, JPMorgan Chase & Co. cut their price target on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a report on Tuesday, November 5th. Four research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $256.50.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.